Zoono Group Limited

Zoono Group Limited

ZOONF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$17.72M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zoono Group LimitedZoono Group Limited-10--179%-0.1
$-0.01

Current Fair Value

120.7% downside

Overvalued by 120.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$17.72 Million
Enterprise Value$17.80 Million
Earnings per Share$0
Beta1.21
Outstanding Shares406,211,764

Return

Return on Equity-179.25%ROE
Return on Assets-98.77%
Return on Invested Capital-114.50%

Valuation & Multiples

P/E Ratio-10P/E Ratio
PEG12.68PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue6.82
Enterprise Value to EBIT-3.62
Enterprise Value to Net Income-4
Total Debt to Enterprise0.02
Debt to Equity0.1Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 27, 2026
EPS
-$0.00
Reported
Revenue
$702,681
Reported

Next Earnings Call

Expected Date
February 25, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Zoono Group Limited

2 employees
CEO: Paul Hyslop

Zoono Group Limited, along with its associated entities, specializes in the innovation, development, and global distribution of a variety of antimicrobial solutions, catering to both the New Zealand market and international clientele. Th...

Questions & Answers